'Together, these data implicate IL-6 signalling in ongoing CD4 T cell activation in DS and offer a more specific therapeutic target than Jak inhibition for consideration by physicians treating individuals with DS.'

#Immunology #DownSyndrome

https://www.nature.com/articles/s41586-023-05736-y